Nguyen BT et al. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection. PLoS Biology 2023.
Lingas G et al. Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis. Clinical Pharmacology and Therapeutics 2023.
Kerioui M et al. Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancer. Biometrics 2023.
Clairon Q et al. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2. PLoS Computational Biology 2023.
Marc A et al. Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates. PLoS Computational Biology 2023.
Mitja O et al. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain. The Lancet Infectious Diseases 2022.
El Messaoudi S et al. A semi-mechanistic model to characterize the long-term dynamic of HBV markers during treatment with lamivudine and Peg-IFN. Clinical Pharmacology and Therapeutics 2022.
Marlin R et al. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates. Nature communications 2022.
Delattre R et al. Combination of in vivo phage therapy data with in silico model highlights key parameters for treatment efficacy. Cell Reports 2022.
Lingas G et al. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modeling analysis of the randomized, controlled, open-label DisCoVeRy trial. Journal of Antimicrobial Chemotherapy 2022.
Marc A et al. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. Elife 2021.
Maisonnasse P et al. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models. Nature Communications 2021.
Gonçalves A et al. SARS-CoV-2 viral dynamics in non-human primates. PLoS Computational Biology 2021.
Néant et al. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients: results from the French Covid-19 cohort. PNAS 2021.
Czuppon P et al. Success of prophylactic antiviral therapy for SARS-CoV-2: predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Computational Biology 2021.
Tardivon C et al . Association between tumor size kinetics and survival in urothelial carcinoma patients treated with atezolizumab: implication for patient’s follow-up. Clinical Pharmacology & Therapeutics 2019; 106: 810-820.